Mary BethScholandMD
Pulmonology • Salt Lake City, UTCritical Care Medicine, Pleural Disease
Assistant Professor, Internal Medicine, University of Utah School of Medicine
Are you Dr. Scholand?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 70 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
50 N Medical Dr
Salt Lake City, UT 84132Phone+1 801-581-7806- Is this information wrong?
Summary
- Dr. Mary Beth Scholand, MD is a pulmonologist in Salt Lake City, Utah. She is currently licensed to practice medicine in Utah, Wyoming, and Montana. She is affiliated with University of Utah Health, George E. Wahlen Department of Veterans Affairs Medical Center, and LDS Hospital.
Education & Training
University of Utah HealthFellowship, Pulmonary Disease and Critical Care Medicine, 1998 - 2002
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1990 - 1993- Washington University in St. Louis School of MedicineClass of 1990
Certifications & Licensure
UT State Medical License 2001 - 2026
MT State Medical License 2022 - 2024
ID State Medical License 2020 - 2023
WY State Medical License 2022 - 2023
CO State Medical License 1993 - 2005- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPF Start of enrollment: 2009 Oct 01
- Long-term Oxygen Treatment Trial Start of enrollment: 2009 Jan 01
- AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis Start of enrollment: 2009 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- Design of the STRIVE-IPF trial- study of therapeutic plasma exchange, rituximab, and intravenous immunoglobulin for acute exacerbations of idiopathic pulmonary fibrosis.Tejaswini Kulkarni, Gerard J Criner, Daniel J Kass, Ivan O Rosas, Mary Beth Scholand, Daniel F Dilling, Ross Summer, Steven R Duncan> ;BMC Pulmonary Medicine. 2024 Mar 20
- Design of the STRIVE-IPF Trial- Study of Therapeutic Plasma Exchange, Rituximab, and Intravenous Immunoglobulin for Acute Exacerbations of Idiopathic Pulmonary Fibrosis.Tejaswini Kulkarni, Gerard J Criner, Daniel J Kass, Ivan O Rosas, Mary Beth Scholand, Daniel F Dilling, Ross Summer, Steven R Duncan> ;Research Square. 2024 Feb 28
- 4 citationsTreatment of Systemic Sclerosis-associated Interstitial Lung Disease: Evidence-based Recommendations. An Official American Thoracic Society Clinical Practice Guideline.Ganesh Raghu, Sydney B Montesi, Richard M Silver, Tanzib Hossain, Madalina Macrea, Derrick Herman, Hayley Barnes, Ayodeji Adegunsoye, Arata Azuma, Lorinda Chung, Grego...> ;American Journal of Respiratory and Critical Care Medicine. 2024 Jan 15
- Join now to see all
Press Mentions
Comprehensive COVID-19 ‘Long-Hauler’ Clinic Opens at U of U HealthJune 3rd, 2021- Joint 3i/U2M2 Project Grants Open Pathways for Infectious Disease ResearchApril 29th, 2021
Officials Break Ground on U. Facility Expected to Increase University Hospital's CapacityJune 30th, 2017
Hospital Affiliations
University of Utah HealthSalt Lake City, Utah
LDS HospitalSalt Lake City, Utah
George E. Wahlen Department of Veterans Affairs Medical CenterSalt Lake City, Utah
